Department of Urology, Pusan National University Yangsan Hospital, Yangsan, Korea.
Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Neurourol Urodyn. 2019 Jun;38(5):1392-1398. doi: 10.1002/nau.23998. Epub 2019 Apr 3.
To evaluate the patterns and predictive factors associated with Hunner lesions (HLs) recurrence in patients with interstitial cystitis (IC).
This study was a retrospective analysis of data from patients with IC who underwent transurethral resection and cauterization (TUR-C) of HLs between October 2011 and December 2017. Symptoms were evaluated using the Pelvic Pain and Urgency/Frequency Patient Symptom Scale (PUF), O'Leary-Sant Interstitial Cystitis Symptom Index, and Visual Analogue Scale (VAS). Patients attended follow-up visits every 3 months; cystoscopy was performed immediately in patients with aggravated symptoms. Recurrence was defined as a VAS score greater than or equal to 4 and HLs recurrence on cystoscopy.
A total of 91 patients were enrolled (25 male, 66 female): median follow-up was 30.6 months. HLs recurrence occurred in 101 sites (53 patients), 21.8% in the previous TUR-C site, 18.8% de novo, and 59.4% at both previous and de novo sites. The recurrence rate was approximately 12.7%, 40%, and 55.2% at 6, 12, and 18 months, respectively. A higher PUF bother score was the only predictive factor of recurrence (odds ratio: 1.142, 95% confidence interval: 1.016-1.284, P = 0.026), with a cut-off value of 7.5 (sensitivity: 67.9%, specificity: 62.5%). In case of late recurrence (>18 months), there was no predictive factor.
The HLs recurrence pattern was unpredictable, involving both previous TUR-C and de novo areas. More accurately defining the HLs resection margin may lead to better surgical outcomes but this remains to be proven.
评估间质性膀胱炎(IC)患者中与 Hunner 病变(HLs)复发相关的模式和预测因素。
本研究为回顾性分析,纳入 2011 年 10 月至 2017 年 12 月间行经尿道 HLs 电切及电灼术(TUR-C)的 IC 患者。采用盆腔疼痛和急迫/频率患者症状量表(PUF)、O'Leary-Sant 间质性膀胱炎症状指数和视觉模拟量表(VAS)评估症状。患者每 3 个月进行一次随访,症状加重时立即行膀胱镜检查。复发定义为 VAS 评分≥4 分和膀胱镜下 HLs 复发。
共纳入 91 例患者(男 25 例,女 66 例),中位随访时间为 30.6 个月。101 处(53 例患者)出现 HLs 复发,21.8%位于前次 TUR-C 部位,18.8%为新发病灶,59.4%位于前次和新发病灶。复发率分别为 6、12、18 个月时的 12.7%、40%和 55.2%。PUF 困扰评分较高是复发的唯一预测因素(比值比:1.142,95%置信区间:1.016-1.284,P=0.026),截断值为 7.5(敏感性:67.9%,特异性:62.5%)。对于迟发性复发(>18 个月),无预测因素。
HLs 复发模式不可预测,既涉及前次 TUR-C 部位,也涉及新发病灶。更准确地定义 HLs 切除边界可能会带来更好的手术效果,但这仍有待证实。